Alexander Fleming’s discovery of penicillin began with a contaminated laboratory culture. Its medical importance, however, depended on more than chance: Fleming recognised that mould had cleared nearby bacteria, investigated the effect and kept pursuing the substance when it attracted little attention. Scientists including Howard Florey and Ernst Chain later found ways to purify and produce penicillin in useful quantities. The result was a landmark in medicine—and a story of discovery, persistence and collaboration rooted in Scotland and London.
From Ayrshire to St Mary’s
Fleming was born on 6 August 1881 at Lochfield farm, near Darvel in Ayrshire, Scotland. He was the third of four children of Hugh Fleming and Grace Stirling Morton. His father died when Alexander was seven. Fleming attended schools in the area before earning a scholarship to Kilmarnock Academy and moving to London. There he studied at the Royal Polytechnic Institution and, in 1901, enrolled at St Mary’s Hospital Medical School. He qualified in 1906.
Fleming had joined the rifle club at medical school. The club’s captain, keen to keep him on the team, suggested he join the research department. Fleming became an assistant bacteriologist to Sir Almroth Wright, whose work focused on vaccine therapy and immunology. He earned a bacteriology degree with a gold medal in 1908 and became a lecturer at St Mary’s.
During the First World War, Fleming served in the Royal Army Medical Corps, rising from lieutenant to captain. He and colleagues worked in battlefield hospitals in France, where he saw soldiers die from infected wounds. His observations informed a 1917 paper about antiseptics: they could be effective on a wound’s surface, he argued, but might fail to reach bacteria in deep wounds and could also harm protective substances in the body. This experience helped shape the questions he pursued as a bacteriologist.
Two discoveries at the laboratory
In 1921, Fleming found that nasal mucus could inhibit bacterial growth. He tested other bodily substances, including tears, and identified an antibacterial enzyme, which he named lysozyme. He published his findings in 1922. The enzyme was not an effective treatment for many disease-causing bacteria, but the work established another important part of his scientific record: he was investigating the body’s own ways of resisting microbes before penicillin entered the story.
Fleming was studying staphylococci when he noticed, on returning from a family holiday in September 1928, that a culture plate had been contaminated by a fungus. The bacterial colonies close to the fungus had disappeared, while those farther away remained. He grew the mould and tested its effect, finding that it acted against several bacteria, including staphylococci. He named the active substance penicillin in 1929.
The familiar account of an uncovered dish captures the accident but not the full scientific process. Fleming had to notice the clear area around the mould, grow it in culture and test its effect on different organisms. The fungus’s identity was also revised over time: it was first identified as Penicillium notatum, but later resolved as Penicillium rubens. Fleming’s observation did not itself produce a medicine ready for widespread use.
From laboratory finding to medicine
Fleming published his penicillin work in 1929, but it drew little attention. Producing the substance in quantity and isolating it were difficult, and his attempts to find help with chemical purification did not solve those problems. He continued to investigate penicillin rather than simply abandoning it. In 1941, he published a method for assessing its effectiveness.
Meanwhile, at Oxford, Ernst Chain and Howard Florey’s team worked on purification and practical production. Edward Abraham proposed the correct molecular structure, and Norman Heatley devised a way to transfer the active ingredient back into water. The team produced a stable form suitable for testing and developed methods that could support larger-scale production. Fleming had discovered and named penicillin; the Oxford researchers and others helped turn that laboratory finding into a drug.
A case in 1942 brought the work into wider view. Harry Lambert, suffering from streptococcal meningitis, was treated with an incompletely purified sample supplied by Florey. Fleming administered it, and Lambert recovered. The case helped draw attention to penicillin’s medical potential. British and American wartime efforts then supported production and distribution. By D-Day in 1944, enough had been made to treat the wounded among Allied troops.
Penicillin was not effective against every bacterium: Fleming’s tests showed that some organisms were unaffected. Nor did its discovery mean that every infection became readily manageable. Its development nevertheless established the beginning of modern antibiotic treatment and helped make penicillin a powerful tool against bacterial disease. The achievement belongs to a chain of work: Fleming’s observation and continued investigations, followed by the purification, testing and production efforts of many other researchers and institutions.
Recognition, caution and remembrance
Fleming, Florey and Chain shared the 1945 Nobel Prize in Physiology or Medicine for the discovery of penicillin and its curative effect in infectious diseases. Fleming had been knighted by King George VI in 1944 and was elected a Fellow of the Royal Society in 1943. He later served as Rector of the University of Edinburgh for a three-year term beginning in 1951.
He also warned that careless use of penicillin could encourage resistant bacteria. In a 1945 statement, he cautioned against using too little or taking the drug for too short a time. The warning anticipated a lasting challenge in medicine: antibiotic treatment must be used with care if it is to remain effective.
Fleming married Sarah Marion McElroy, a nurse, in 1915; they had one son, Robert. After Sarah’s death in 1949, he married his St Mary’s colleague Amalia Koutsouri-Vourekas in 1953. Fleming died at his London home on 11 March 1955. His ashes were buried in St Paul’s Cathedral. The laboratory at St Mary’s where he discovered penicillin is preserved as the Alexander Fleming Laboratory Museum.
Why Alexander Fleming deserves a place in British Legacy
Fleming’s place in British Legacy rests on a specific scientific achievement and the work that made it matter. At St Mary’s Hospital in London, he recognised that a mould could destroy nearby bacteria, investigated the substance and gave it the name penicillin. That observation opened a path towards an effective antibiotic at a time when bacterial infections could be devastating. His earlier research on lysozyme and his wartime observations about antiseptics also show a bacteriologist attentive to how infection works and how treatment can fail.
The legacy is not a story of one man producing a finished cure alone. Fleming’s contribution was essential, but Florey, Chain, Heatley, Abraham and many others helped purify, test and manufacture penicillin. Recognising that collaboration makes the achievement clearer, not smaller: discovery has public value when other people can develop it into treatment. Fleming’s warning about resistance adds a practical lesson that remains relevant to the use of antibiotics. Born in Ayrshire and working for much of his scientific life at a London hospital, he connects Scottish origins with British medical research and a discovery whose benefits reached far beyond Britain.
Sources
Alexander Fleming — Wikipedia, revision 1375868973 · Alexander Fleming — Wikipedia
Adapted in part from Alexander Fleming by Wikipedia contributors, under CC BY-SA 4.0. Text has been edited and combined with the existing article; this adapted text is shared under the same licence. Contributor history.
